U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 2

Figure 2. Correlation between serum levels of TRAIL and negative prognostic markers.. From: Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction.

Inverse correlation between serum levels of TRAIL and CK (A), between TRAIL and CK-MB (B) and between TRAIL and BNP (C) in AMI patients. Coefficients of correlation (R) are indicated.

Paola Secchiero, et al. PLoS One. 2009;4(2):e4442.
2.
Figure 1

Figure 1. Serum TRAIL levels in AMI patients and healthy individuals.. From: Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction.

Levels of TRAIL were determined by ELISA in sera from AMI patients (analyzed at the indicated times post AMI) and from healthy control subjects. Horizontal bars are median, upper and lower edges of box are 75th and 25th percentiles, lines extending from box are 10th and 90th percentiles.

Paola Secchiero, et al. PLoS One. 2009;4(2):e4442.
3.
Figure 3

Figure 3. Serum TRAIL levels in AMI patient with respect to adverse clinical events.. From: Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction.

Serum levels of TRAIL were analyzed in AMI patient who died or experienced HF (with events) either during the acute phase (in-hospital) or in the follow-up (12 months after AMI) with respect to the other AMI patients (without events). Horizontal bars are median, upper and lower edges of box are 75th and 25th percentiles, lines extending from box are 10th and 90th percentiles.

Paola Secchiero, et al. PLoS One. 2009;4(2):e4442.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center